Skip to main content
Premium Trial:

Request an Annual Quote

Aussie Proteome-Analysis Facility, Lumicyte Partner In Proteomic Biomarker Discovery

NEW YORK, Nov. 19 (GenomeWeb News) - The Australian Proteome Analysis Facility will partner with LumiCyte to develop LCI's STS biochip platform technology and to accelerate proteomic biomarker discovery, the facility said today.

 

Under terms of the agreement, LCI will provide access to its STS biochip platform to support APAF's biomarker discovery-research efforts. Using mass-spectrometry techniques, APAF will provide a range of evaluation, validation and showcasing proteomic studies to characterize the performance of the STS platform.

 

APAF and LCI will apply collaboratively to the Australian government for funding to support the STS platform research.

 

Financial terms of the collaboration were not disclosed.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.